Singulair Uses, Dosage & Side Effects - Drugs.com
2024年4月8日 · Singulair (montelukast) is used to prevent asthma attacks in adults and children as young as 12 months old. Includes Singulair side effects, interactions and indications.
Singular (Singulair) Information from Drugs.com
Singular is a common misspelling of Singulair (montelukast). What is Singulair (Singular)? Singulair (Singular) is used for the prevention and long-term treatment of asthma attacks in …
Singulair: 7 things you should know - Drugs.com
2023年11月13日 · Quick easy-to-read overview of Singulair. Includes: how it works, upsides, downsides, bottom line, tips, response and effectiveness.
Singulair Dosage Guide - Drugs.com
2024年10月15日 · Instructions for Administration of Oral Granules. SINGULAIR 4-mg oral granules can be administered either directly in the mouth, dissolved in 1 teaspoonful (5 mL) of …
How long does Singulair stay in your system? - Drugs.com
2024年10月24日 · Singulair (montelukast) will be in your system for approximately 30.3 hours. The mean plasma half-life of montelukast ranges from 2.7 to 5.5 hours in healthy young …
Singulair: Package Insert / Prescribing Info - Drugs.com
2024年10月21日 · SINGULAIR is a leukotriene receptor antagonist indicated for: Prophylaxis and chronic treatment of asthma in patients 12 months of age and older ().
Montelukast vs Singulair Comparison - Drugs.com
Compare Montelukast vs Singulair head-to-head with other drugs for uses, ratings, cost, side effects and interactions.
Singulair Side Effects: Common, Severe, Long Term - Drugs.com
2024年12月11日 · Learn about the side effects of Singulair (montelukast), from common to rare, for consumers and healthcare professionals.
Singulair Reviews & Ratings - Drugs.com
Singulair User Reviews & Ratings. Singulair has an average rating of 6.6 out of 10 from a total of 149 reviews on Drugs.com. 54% of reviewers reported a positive experience, while 30% …
Generic Singulair Availability - Drugs.com
1998年2月20日 · Generic Singulair Availability. Last updated on Dec 12, 2024. Singulair is a brand name of montelukast, approved by the FDA in the following formulation(s):